| Months After Starting | ALT (U/L) | Total Bilirubin (mg/dL) | Retics (%) | Hct (%) | HCV RNA (million IU/mL) |
|---|---|---|---|---|---|
| Pre | 123 | 0.9 | 1.0 | 50.3 | 6.5 |
| 0 | 148 | 1.5 | 2.4 | 49.2 | 3.4 |
| Ribavirin (1200 mg daily) started | |||||
| 1 | 85 | 1.7 | 8.8 | 41.0 | 2.6 |
| 2 | 65 | 2.0 | 9.3 | 39.7 | 2.5 |
| 4 | 35 | 2.1 | 10.4 | 36.4 | 2.5 |
| 6 | 47 | 1.5 | 11.7 | 38.8 | 1.9 |
| 8 | 54 | 3.1 | 9.3 | 39.7 | 1.8 |
| 12 | 43 | 1.9 | 9.9 | 37.9 | 1.8 |
| Ribavirin stopped and patient followed on no therapy | |||||
| +1 | 72 | 0.6 | 2.4 | 48.0 | |
| +2 | 212 | 0.8 | 1.3 | 48.6 | 3.0 |
| +6 | 157 | 1.4 | 1.3 | 49.0 | |
| Normal Values | <42 | <1.2 | <1.0 | >38 | None |
From: Ribavirin
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.